The University of Texas, MD Anderson Cancer Center - League City — League City, Texas

The University of Texas, MD Anderson Cancer Center - League City is a clinical research site located in League City, Texas, United States 77573.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Texas, MD Anderson Cancer Center - League City has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas, MD Anderson Cancer Center - League City?

The University of Texas, MD Anderson Cancer Center - League City has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas, MD Anderson Cancer Center - League City conducted?

The University of Texas, MD Anderson Cancer Center - League City has 3 clinical trials on record, with 3 currently active. Their work covers Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma.

Is The University of Texas, MD Anderson Cancer Center - League City accredited by Crixeo Health?

The University of Texas, MD Anderson Cancer Center - League City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas, MD Anderson Cancer Center - League City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.